Evofem Biosciences - Stock Price History | EVFM

Historical daily share price chart and data for Evofem Biosciences since 2022 adjusted for splits. The latest closing stock price for Evofem Biosciences as of May 20, 2022 is 0.41.
  • The all-time high Evofem Biosciences stock closing price was 1306.79 on August 04, 2015.
  • The Evofem Biosciences 52-week high stock price is 21.29, which is 5092.7% above the current share price.
  • The Evofem Biosciences 52-week low stock price is 0.40, which is 2.4% below the current share price.
  • The average Evofem Biosciences stock price for the last 52 weeks is 8.92.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Evofem Biosciences Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2021 21.0805 38.2309 73.1634 5.5577 5.6297 -84.42%
2020 56.5051 88.1559 102.8486 31.0345 36.1319 -60.94%
2019 73.3592 62.2189 107.0465 48.7256 92.5037 47.26%
2018 75.8854 189.7671 189.7671 29.3853 62.8186 -64.18%
2017 113.9943 100.7295 224.8426 28.7799 175.3772 74.11%
2016 90.6226 127.7106 129.5093 51.5699 100.7295 -19.42%
2015 754.7006 661.9366 1306.7851 113.3207 125.0125 -81.42%
2014 754.7452 1079.2444 1079.2444 575.5970 672.7290 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.005B $0.008B
Evofem Biosciences Inc. develops and anticipates commercializing products which support and promote women as the primary healthcare consumer. The company is identifying and developing new and novel products which specifically address unmet needs in the areas of sexual and reproductive health, the prevention of acquisition of sexually transmitted infections and products which address or promote general health and wellbeing. Evofem Biosciences Inc., formerly known as Neothetics Inc., is based in SAN DIEGO CA.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $162.213B 9.87
Bio-Rad Laboratories (BIO.B) United States $15.121B 32.79
QIAGEN (QGEN) Netherlands $10.280B 16.23
Biohaven Pharmaceutical Holding (BHVN) United States $10.017B 0.00
Ginkgo Bioworks Holdings (DNA) United States $4.593B 0.00
Emergent Biosolutions (EBS) United States $1.775B 7.60
Arcus Biosciences (RCUS) United States $1.357B 34.40
Myovant Sciences (MYOV) United Kingdom $1.000B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.486B 0.00
Gelesis Holdings (GLS) United States $0.360B 0.00
Zymeworks (ZYME) Canada $0.346B 0.00
Ambrx Biopharma (AMAM) United States $0.149B 0.00
Enzo Biochem (ENZ) United States $0.116B 23.80
SQZ Biotechnologies (SQZ) United States $0.099B 0.00